Gomez J A, Diehl A K
Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 78284-7879.
Am J Med. 1992 Jun;92(6):603-6. doi: 10.1016/0002-9343(92)90777-9.
A stool guaiac test is often performed on newly hospitalized patients as part of the admission evaluation. However, little is known regarding the value of testing stool obtained by digital rectal examination. We sought to document the use of the admission stool guaiac test in a teaching hospital, to determine its diagnostic yield, and to assess its potential benefit to patients.
We performed a retrospective review of the medical records for 264 consecutive patients admitted to internal medicine services during a single month, of whom 202 received a stool guaiac test on admission. Information was collected on the frequency of guaiac testing, indications for testing, test results, and diagnoses established.
Criteria were established to distinguish "clinically indicated" from "routine" use of the admission stool guaiac test. Indicated tests were positive more often than routinely performed tests (35% versus 11%, p less than 0.001). Most patients with positive tests received further testing for gastrointestinal disease, whether or not the test was indicated. Of 104 patients with indications, 25 were ultimately found to have gastrointestinal lesions, most of which were clinically important. Of 98 patients tested routinely, only four had diagnoses established, of whom three had benign conditions. Four of five patients with cancer had clinical indications for testing. The fifth was diagnosed only after he experienced gross rectal bleeding several days after admission.
Like other commonly applied diagnostic tests, the stool guaiac test obtained during the admission physical examination is best reserved for patients whose clinical presentation provides a reason for testing. In patients without clinical indications, the test is of uncertain value and only infrequently leads to important diagnoses.
粪便隐血试验常作为新入院患者入院评估的一部分进行。然而,对于通过直肠指检获取的粪便进行检测的价值,人们了解甚少。我们试图记录一家教学医院入院时粪便隐血试验的使用情况,确定其诊断率,并评估其对患者的潜在益处。
我们对一个月内连续入住内科病房的264例患者的病历进行了回顾性研究,其中202例患者入院时接受了粪便隐血试验。收集了隐血试验的频率、检测指征、检测结果和确诊情况等信息。
制定了区分入院粪便隐血试验“临床指征性”与“常规”使用的标准。有指征的检测阳性率高于常规检测(35%对11%,p<0.001)。大多数检测阳性的患者接受了胃肠道疾病的进一步检查,无论检测是否有指征。在104例有指征的患者中,最终发现25例有胃肠道病变,其中大多数具有临床重要性。在98例常规检测的患者中,只有4例确诊,其中3例为良性疾病。5例癌症患者中有4例有检测的临床指征。第5例患者在入院几天后出现直肠大出血后才被诊断。
与其他常用的诊断检查一样,入院体格检查时进行的粪便隐血试验最好仅用于那些临床表现提示有检测理由的患者。对于没有临床指征的患者,该检查价值不确定,很少能得出重要诊断。